🔥 BREAKING: THEMA US5015751044 | Don't Miss This! 💥

Sie befinden sich hier: Startseite > Themen > US5015751044?lang=en

Thema: US5015751044

KYMR, US5015751044

Raymond James sets USD 140 target for Kymera Therapeutics stock

tesla-6537378_1920.jpg - Foto: THN

Kymera reported USD 65.00 million revenue in Q2 2026 versus USD 32.78 million expected. Citi raised its target for Kymera Therapeutics stock to USD 150.

ad-hoc-news.de, 16.10.26 03:16 Uhr

thai-1549085_1920.jpg - Foto: THN

KYMR, US5015751044

Raymond James set a USD 140.00 target for Kymera Therapeutics ...

Citi lifted its target to USD 150.00 from USD 135.00 on October 5, 2026. For Kymera Therapeutics stock, revenue reached USD 65.00 million in June 2026.

ad-hoc-news.de, 14.10.26 03:11 Uhr

money-733983_1920.jpg - Foto: THN

KYMR, US5015751044

Kymera Therapeutics stock fell 3.52 percent on October 6 ...

Kymera Therapeutics stock stood at USD 105.98 on October 6 2026 18.51 percent below the 52-week high. Q2 revenue reached USD 65.0 million up 465.2 percent year over year. ...

ad-hoc-news.de, 07.10.26 06:28 Uhr

usa-3004860_1920.jpg - Foto: THN

KYMR, US5015751044

B.Riley keeps Buy rating for Kymera Therapeutics stock

Kymera Therapeutics stock drew a USD 155.00 target from B.Riley on October 1, 2026. Q2 revenue reached USD 65.00 million versus USD 11.50 million.

ad-hoc-news.de, 02.10.26 13:32 Uhr